Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes.

about

Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes.

Item

http://www.wikidata.org/entity/Q47102317

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Early intervention in the mana ...... linical and economic outcomes.

@en

Early intervention in the mana ...... linical and economic outcomes.

@nl

type

Item

label

Early intervention in the mana ...... linical and economic outcomes.

@en

Early intervention in the mana ...... linical and economic outcomes.

@nl

prefLabel

Early intervention in the mana ...... linical and economic outcomes.

@en

Early intervention in the mana ...... linical and economic outcomes.

@nl

P1476

Early intervention in the mana ...... linical and economic outcomes.

@en

P2093

Charles D Burger

http://www.w3.org/2001/XMLSchema#string

Divya Padmanabhan Menon

http://www.w3.org/2001/XMLSchema#string

Mohamedanwar Ghandour

http://www.w3.org/2001/XMLSchema#string

Raymond L Benza

http://www.w3.org/2001/XMLSchema#string

P2860

Medical treatment update on pulmonary arterial hypertension

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.

Riociguat for the treatment of pulmonary arterial hypertension.

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients.

P304

731-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/CEOR.S119117

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haytham Helmi

P577

2017-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29200882

http://www.w3.org/2001/XMLSchema#string

P932

5703162

http://www.w3.org/2001/XMLSchema#string